The Silicon Review ^Asia

Bangalore’s medical institute, NIMHANS has made a partnership with University Of Alberta, Canada in order to develop AI capabilities which can precisely diagnose schizophrenia.

Dubbed as EMPaSchiz, the model utilized MRI data of more than 81 patients suffering from Schizophrenia- generally, AI models shift trough much bigger data sets. The researchers kept the patients away from psychoactive drugs in order to avoid any kind oferrorin the results.

As per the results, the new AI model provided accurate results of 90 percent and beat other models created to treat the same disease.

The AI study started when Software Behemoth, Microsoft joined hands with Apollo hospitals recently in order to roll out an API (application programme interface) for computing heart disease risk score. It is powered nu am AI in some rural parts of India. The company also collaborated with Bangalore’s healthcare unit Narayana Health to deliver cancer detecting real-time data analysis.

The research work was showcased in a journal known as npj Schizophrenia, It reveals about how the researchers utilized data from MRI of affected brains to develop the model for diagnosis.

As per the researchers, AI’s future use can effectively use to create markers which canprovide in depth details about schizophrenia. The medicines which are currently available to treat the disease are limited towards treating the disease in fact the disease as a whole remain elusive.

AI is considered as the future of healthcare, where it can effectively manage compiling, medical records and also analyse information.